Latigo Biotherapeutics, Inc. (LTGO): 10-Q filed Nov 5, 2026

Form type

10-Q

Filing date

Nov 5, 2026

Accession number

0001193125-26-448582

Filer

Latigo Biotherapeutics, Inc. (CIK 2056611)